Key Laboratory for Regenerative Medicine, Ministry of Education, School of Biomedical Sciences, Faculty of Medicine, CUHK-GIBH Joint Research Laboratory on Stem Cells and Regenerative Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
Institute for Tissue Engineering and Regenerative Medicine (iTERM), The Chinese University of Hong Kong, Hong Kong SAR, China.
J Cell Mol Med. 2020 Mar;24(6):3256-3270. doi: 10.1111/jcmm.15039. Epub 2020 Feb 10.
The CRISPR-Cas technologies derived from bacterial and archaeal adaptive immune systems have emerged as a series of groundbreaking nucleic acid-guided gene editing tools, ultimately standing out among several engineered nucleases because of their high efficiency, sequence-specific targeting, ease of programming and versatility. Facilitated by the advancement across multiple disciplines such as bioinformatics, structural biology and high-throughput sequencing, the discoveries and engineering of various innovative CRISPR-Cas systems are rapidly expanding the CRISPR toolbox. This is revolutionizing not only genome editing but also various other types of nucleic acid-guided manipulations such as transcriptional control and genomic imaging. Meanwhile, the adaptation of various CRISPR strategies in multiple settings has realized numerous previously non-existing applications, ranging from the introduction of sophisticated approaches in basic research to impactful agricultural and therapeutic applications. Here, we summarize the recent advances of CRISPR technologies and strategies, as well as their impactful applications.
CRISPR-Cas 技术源自细菌和古菌的适应性免疫系统,已成为一系列突破性的核酸制导基因编辑工具。由于其高效性、序列特异性靶向、易于编程和多功能性,最终在几种工程化核酸酶中脱颖而出。借助生物信息学、结构生物学和高通量测序等多个学科的进步,各种创新的 CRISPR-Cas 系统的发现和工程正在迅速扩展 CRISPR 工具包。这不仅正在彻底改变基因组编辑,还正在彻底改变转录控制和基因组成像等其他类型的核酸制导操作。与此同时,各种 CRISPR 策略在多种环境中的适应已经实现了许多以前不存在的应用,从基础研究中引入复杂方法到具有重大影响的农业和治疗应用。在这里,我们总结了 CRISPR 技术和策略的最新进展及其有影响力的应用。